CVS Sues Takeda Over `Pay-For-Delay` Scheme
10 Sep 2025 //
FIERCE PHARMA
Takeda eyes upcoming launches as Vyvanse generics hit lingers
09 May 2025 //
FIERCE PHARMA
DEA Increases Production Limits on Takeda`s Vyvanse Amid Ongoing Shortages
05 Sep 2024 //
FIERCE PHARMA
Alembic Pharma Gets USFDA Nod for Generic Hereditary Angioedema Injection
17 Jun 2024 //
ECONOMICTIMES
Takeda plots $900M restructuring plan as profits plummet
10 May 2024 //
FIERCE PHARMA
Amid shortage, FDA clears several generics of Takeda`s Vyvanse
31 Aug 2023 //
FIERCE PHARMA
Takeda focuses on Qdenga as it braces for Vyvanse generics
27 Jul 2023 //
FIERCE PHARMA
CHMP Recommends One New Drug, Begins Review of Indian CRO
29 Feb 2020 //
RAPS
MSN Labs subsidiary, Novadoz Pharma gets US FDA approval for generic Uloric
01 Jan 2020 //
PHARMABIZ
Does Stada need Takeda`s for-sale European drugs? CEO says no
15 Aug 2019 //
FIERCE PHARMA
Takeda outlook, generics suit and more—FiercePharmaAsia
17 May 2019 //
FIERCE PHARMA
Cerdelga (eliglustat) : Genzyme vs. Cipla Ltd.
24 Nov 2018 //
PATENT LITIGATION
AMITIZA® (lubiprostone) : Sucampo Pharmaceuticals vs. Sun Pharmaceutical
31 Oct 2018 //
PATENT LITIGATION
Drugmakers Call for Changes, Additions to FDA’s Purple Book
27 Sep 2018 //
RAPS
Prevacid (lansoprazole): Takeda Pharmaceutical v. Zydus Pharmaceutical
26 Jul 2018 //
PATENT LITIGATION
Prevacid (lansoprazole): Takeda Pharmaceutical Co. Ltd. v. Zydus Pharmaceuticals USA Inc. & Cadila Healthcare Ltd.
23 Jul 2018 //
PATENT LITIGATION
Trintellix (vortioxetine hydrobromide): H. Lundbeck A/S, Takeda Pharmaceutical Company Ltd. v. Apicore US LLC
16 Jul 2018 //
PATENT LITIGATION
Trintellix® ( vortioxetine hydrobromide): H. Lundbeck v. Torrent Pharma
03 May 2018 //
PATENT LITIGATION
Trintellix® ( vortioxetine hydrobromide): H. Lundbeck v. Sigmapharm Lab
03 May 2018 //
PATENT LITIGATION
Colcrys® (colchicine, USP): Takeda Pharmaceuticals v. Alkem Laboratories
01 Feb 2018 //
PATENT LITIGATION
Trintellix (Vortioxetine): H. Lundbeck v. Amneal Pharmaceuticals
30 Jan 2018 //
PATENT LITIGATION
Trintellix (Vortioxetine): H. Lundbeck v. Hetero USA
30 Jan 2018 //
PATENT LITIGATION
Trintellix (Vortioxetine): H. Lundbeck v. Sandoz
30 Jan 2018 //
PATENT LITIGATION
Trintellix® (Vortioxetine Hcl): H. Lundbeck v. Zydus Pharmaceuticals (USA)
26 Jan 2018 //
PATENT LITIGATION
Trintellix® (Vortioxetine Hydrobromide): H. Lundbeck V. Zydus Pharma (USA)
25 Jan 2018 //
PATENT LITIGATION
Trintellix® (Vortioxetine Hydrobromide): H. Lundbeck v. Cipla Limited
25 Jan 2018 //
PATENT LITIGATION
Colcrys® (Colchicine, Usp):Takeda Pharmaceuticals Usa V. Dr. Reddys Laboratories
17 Jan 2018 //
PATENT LITIGATION
Kazano® (Alogliptin Benzoate & Metformin Hcl):Takeda V. Indoco Remedies
02 Jan 2018 //
PATENT LITIGATION
Takeda Submits Vedolizumab NDA for Treatment of Moderately to Severe UC in Japan
24 Aug 2017 //
DDDMAG
U.S. court upholds Takeda patent on cancer drug Velcade
18 Jul 2017 //
REUTERS
Nesina®, Kazano®, & Oseni® : Takeda Pharmaceutical V. Torrent Pharmaceuticals
05 May 2017 //
PATENT LITIGATION
Amitiza (Lubiprostone): Sucampo & Takeda v. Amneal Pharmaceuticals
13 Apr 2017 //
PATENT LITIGATION
Takeda submits post-marketing Actos study that shows no link to bladder cancer
04 Aug 2015 //
FIERCE PHARMA ASIA
Otsuka scrambles to persuade judge to block Abilify copycats
17 Apr 2015 //
FIERCE PHARMA

Market Place
Sourcing Support